Sobi™ discloses payments to the healthcare professionals and healthcare organisations to increase transparency
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the company has made all payments and transfers of value to healthcare professionals and organisations from 2016 publicly available*, including sponsorships to attend meetings, grants and donations, speaker fees, consultancy and advisory boards in accordance with the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code. The information is made available on Sobi´s corporate web site , starting 31